For the year ending 2025-12-31, DXCM has $6,339,900K in assets. $3,593,900K in debts. $917,700K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 917,700 | 606,100 | 566,300 | 642,300 |
| Short-term marketable securities | 1,081,000 | 1,973,300 | 2,157,800 | 1,813,900 |
| Accounts receivable, net | 1,216,100 | 1,005,700 | 973,900 | 713,300 |
| Inventory | 629,100 | 542,600 | 559,600 | 306,700 |
| Prepaid and other current assets | 189,400 | 173,700 | 168,300 | 192,600 |
| Total current assets | 4,033,300 | 4,301,400 | 4,425,900 | 3,668,800 |
| Property and equipment, net | 1,559,900 | 1,339,900 | 1,113,100 | 1,055,600 |
| Operating lease right-of-use assets | 77,400 | 62,800 | 71,400 | 80,000 |
| Goodwill | 24,200 | 22,800 | 25,200 | 25,700 |
| Intangibles, net | 70,800 | 103,400 | 134,500 | 173,300 |
| Deferred tax assets | 295,600 | 481,200 | 419,400 | 341,200 |
| Other assets | 278,700 | 173,000 | 75,000 | 47,100 |
| Total assets | 6,339,900 | 6,484,500 | 6,264,500 | 5,391,700 |
| Accounts payable and accrued liabilities | 1,944,000 | 1,585,100 | 1,345,500 | 901,800 |
| Accrued payroll and related expenses | 169,200 | 112,000 | 171,000 | 134,300 |
| Current portion of long-term senior convertible notes | 0 | 1,204,400 | 0 | 772,600 |
| Short-term operating lease liabilities | 21,600 | 22,500 | 21,100 | 20,500 |
| Deferred revenue | - | 8,000 | 18,400 | 10,100 |
| Other current liabilities | 7,700 | - | - | - |
| Total current liabilities | 2,142,500 | 2,932,000 | 1,556,000 | 1,839,300 |
| Long-term senior convertible notes | 1,240,900 | 1,237,000 | 2,434,200 | 1,197,700 |
| Long-term operating lease liabilities | 73,400 | 65,000 | 80,100 | 94,600 |
| Other long-term liabilities | 137,100 | 147,900 | 125,600 | 128,300 |
| Total liabilities | 3,593,900 | 4,381,900 | 4,195,900 | 3,259,900 |
| Common stock, 0.001 par value, 800.0 million shares authorized 410.7 million and 384.8 million shares issued and outstanding, respectively, at december31, 2025 and 408.9 million and 390.7 million shares issued and outstanding, respectively, at december31, 2024 | 400 | 400 | 400 | 400 |
| Additional paid-in capital | 2,281,500 | 2,093,800 | 3,514,600 | 2,258,100 |
| Accumulated other comprehensive income (loss) | 115,000 | -8,000 | -16,700 | -11,600 |
| Retained earnings | 2,433,900 | 1,597,600 | 1,021,400 | 479,900 |
| Treasury stock, at cost 25.9 million shares at december31, 2025 and 18.2 million shares at december31, 2024 | 2,084,800 | 1,581,200 | 2,451,100 | 595,000 |
| Total stockholders equity | 2,746,000 | 2,102,600 | 2,068,600 | 2,131,800 |
| Total liabilities and stockholders equity | 6,339,900 | 6,484,500 | 6,264,500 | 5,391,700 |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)